Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michael Longenecker is active.

Publication


Featured researches published by Michael Longenecker.


Archive | 1989

The Potential of Synthetic Tumor-Associated Glycoconjugates (S-TAGs) for Generating Monoclonal Antibodies for Breast Cancer Imaging and for Specific Immunotherapy

Grant D. MacLean; Alexander J.B. McEwan; Eleanor Mackie; Peter Y. S. Fung; Carina Henningsson; R. Rao Koganty; Marian Madej; Thomas R. Sykes; Antoine A. Noujaim; Michael Longenecker

The Thomsen Friedenreich (TF) antigen may be important for the detection and immunotherapy of a number of common cancers including breast cancer. Revealed on normal human erythrocytes by neuraminidase treatment, TF has been characterized as: β-D-Gal-(1–3)- α-GalNAc, attached to glycophorin or other glycoproteins through O-serine or O-threonine linkages (1). Tn, the TF precursor, is reported to be α-GalNAc-O-serine/ threonine. While TF is normally cryptic due to the presence of a terminal sialic acid residue, Tn is exposed in individuals with a recessive genetic disorder (2). Springer (1) has claimed expression of TF and Tn antigens on over 90% of cancers of the breast, lung and pancreas, although the nature of the molecules which bear these antigens and their exact structures has not been defined.


Advances in Experimental Medicine and Biology | 1977

Ontogeny of Hemopoietic Colony-Forming Units in the Chick Embryo Spleen

Gordon Keller; Calliopi Havele; Michael Longenecker; Erwin Diener

Inoculation of spleen cells of chicken embryos onto the chorioallantoic membrane (CAM) of other chicken embryos led to the formation of white (granulocytic) and pink (mixed erythrocytic and granulocytic) hemopoietic colonies. The number of CAM colonies formed was a linear function of the number of cells inoculated indicating that each colony originated from a single colony-forming unit (CAM-CFU). CAM-CFU’s consist of an aggregate of primitive undifferentiated cells which penetrate the ectodermal layer of the CAM, then proliferate and differentiate into mature granulocytes or erythrocytes. Deaggregated CAM-CFU’s failed to form colonies indicating that cell interaction may be required for colony formation. The genetic constitution of the host embryo has no effect on colony formation but mixtures of donor cells from inbred embryo spleen were found to be more efficient colony formers than mixtures of donor cells from non-inbred embryo spleens. Ontogeny studies demonstrated that the chick embryo spleen contains peak hemopoietic activity between fifteen and seventeen days of incubation declining thereafter to undetectable levels two days post hatching. At this time the inoculation of spleen cell suspensions leads to the formation of lymphoid colonies which increase in number with age of the donor.


Journal of the National Cancer Institute | 1982

Antigenic Heterogeneity of Human Colorectal Cancer Cell Lines Analyzed by a Panel of Monoclonal Antibodies. I. Heterogeneous Expression of la-Like and HLA-Like Antigenic Determinants

Grant D. MacLean; Jutta Seehafer; Andrew R. E. Shaw; Mark W. Kieran; Michael Longenecker


Archive | 2000

Synthetic lipid-a analogs and uses thereof

Zi-Hua Jiang; Mimi Bach; Damayanthi Yalamati; R. Rao Koganty; Michael Longenecker


Leukemia Research | 1985

Further evidence for the existence of ‘homing’ receptors on murine leukemia cells which mediate adherence to normal bone marrow stromal cells

B. Boris Kamenov; Michael Longenecker


Archive | 2002

Vaccine for modulating between t1 and t2 immune responses

A. Wladyslaw Edmonton Budzynski; R. Rao Koganty; Mark Edmonton Krantz; Michael Longenecker


Journal of Cellular Physiology | 1980

Hemopoietic colonies on the chorioallantoic membrane of the chick embryo: Induction by embryonic, adherent, non-hemopoietic spleen cells

Gordon Keller; Michael Longenecker; Erwin Diener


Archive | 2002

Impfstoff zur modulation zwischen t1 und t2 immunantworten

A Budzynski; R. Rao Koganty; Mark J. Krantz; Michael Longenecker


Archive | 2002

Impfstoff zur modulation zwischen t1 und t2 immunantworten Reply immune vaccine for modulation between t1 and t2

A. Wladyslaw Edmonton Budzynski; R. Rao Koganty; Mark Edmonton Krantz; Michael Longenecker


Journal of Immunotherapy | 1992

NOVEL SYNTHETIC IMMUNOTHERAPEUTIC VACCINES FOR CANCER: INDUCTION OF HAPTEN- SPECIFIC HUMORAL IMMUNITY WITH REACTIVITY WITH TUMOR CELLS

Grant D. MacLean; Michael Longenecker

Collaboration


Dive into the Michael Longenecker's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge